Curaleaf Holdings Inc

RiverNorth Opportunities Fund, Inc.

AdvisorShares Pure US Cannabis ETF

MSOS is an actively managed narrow portfolio of US stocks or swap contracts related to the domestic cannabis and hemp industry.

Philip Morris

One of the more frustrating trades this year has been the back-and-forth rallies and sell offs in the cannabis sector. MSOS is the ETF stock ticker for US Cannabis.

Cannabis Sector Intriguing: Here's One Stock To Watch

Aurora Cannabis

Canopy Growth

Cronos Group

Tilray Brands

Cannabis stocks are once again on the move today, with some big names being seen across the sector. Shares of Canopy Growth (NASDAQ: CGC ), Tilray (NASDAQ: TLRY ), Aurora Cannabis (NASDAQ: ACB ), AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS ), and Cronos (NASDAQ: CRON ) are all up between 2% and 10% in today's session, with Canopy Growth leading the way higher.

Cannabis Stocks CGC, TLRY, ACB, MSOS, CRON Pop as Justice Department Moves on Rescheduling

Green Thumb Industries Inc.

Innovative Industrial Properties

NewLake Capital Partners, Inc.

OrganiGram Holdings Inc.

SNDL Inc.

Trulieve Cannabis Corp.

Alex Carchidi is bullish on the cannabis sector but not ready to invest in stocks, except for Innovative Industrial Properties. 2 cannabis stocks worth considering are Green Thumb Industries and Trulieve Cannabis.

Looking For The Bud Light Of Cannabis

Cambria Cannabis ETF

AdvisorShares Pure Cannabis ETF 

On this week's episode of ETF Prime, host Nate Geraci is joined by VettaFi Head of Research Todd Rosenbluth to discuss hedge funds embracing ETFs, spot ether ETFs, and a potential shortage of ETF tickers, among other topics. Afterward, Bancreek CEO and CIO Andrew Skatoff spoke with Geraci about his investment philosophy.

ETF Prime: Rosenbluth on Spot Ether, Marijuana ETFs, and More

Sprott Junior Copper Miners ETF

Sprott Copper Miners ETF

Global X Copper Miners ETF

iShares Copper and Metals Mining ETF

Amplify Alternative Harvest ETF

Engine NO 1 Transform Climate ETF

VanEck Vectors Uranium+Nuclear Energy ETF

VanEck Vectors Semiconductor ETF

Invesco PHLX Semiconductor ETF

iShares PHLX Semiconductor ETF

Global X Uranium ETF

Sprott Junior Uranium Miners ETF

Sprott Uranium Miners ETF

Roundhill Cannabis ETF

Looking at the ETFs with the highest returns YTD, a few thematic standouts have emerged.  As a reminder regarding  long-term investments, thematic investing is cyclical.

YTD Thematic Winners Reflect Change in Market Leadership

The U.S. pot sector could see an influx of medical research funding from healthcare investors amid renewed interest from pharmaceutical firms, should a proposal to reclassify cannabis as a lower-risk substance be approved, industry experts said.

US reclassification could drive fresh research funding into pot sector

AFC Gamma

Curaleaf Holdings, Inc.

Cannabis may be one of the most controversial investing topics. But, it's also turning out to be one of the most profitable.

The 7 Most Undervalued Cannabis Stocks to Buy in May 2024

There's growing optimism about marijuana reform after news that officials in the U.S. are looking to reschedule the substance. Canadian pot stocks may be the most popular ones to invest in, but multi-state operators may have the most to gain from marijuana reform.

Bullish on Marijuana Reform? This Cannabis-Focused ETF Could Be the Best Way to Invest in Pot Stocks.

Marijuana ETFs and cannabis stocks shot higher last week after the U.S. Justice Department said it plans to reclassify marijuana as a less dangerous drug.

Investors wary of US cannabis ETFs despite recent rally

New reported plans by the U.S. government could pave the pay for profit in marijuana investing. The White House is reportedly seeking to reclassify marijuana from a Schedule I drug to a Schedule III.

Reclassification Reports Fueling U.S. Marijuana Investing

Tema Obesity & Cardiometabolic ETF

Amplify Global Cloud Technology ETF

Amplify US Alternative Harvest ETF

MUSQ Global Music Industry ETF

VanEck Vectors Pharmaceutical ETF

First Trust Cloud Computing ETF

Digging into the first quarter's earnings season allows us to uncover the winning themes of the period as captured by ETFs.

Thematic ETF Winners of the Q1 2024 Earnings Season

The proposed rescheduling of cannabis is the biggest step forward for the industry in decades.

Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling

AdvisorShares Pure US Cannabis ETF ( MSOS ) is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 137.66% from its 52-week low price of $4.78/share.

Cannabis ETF (MSOS) Hits New 52-Week High

iShares Core U.S. Aggregate Bond ETF

ARK 21Shares Bitcoin ETF

ARK Genomic Revolution Multi-Sector ETF

Aberdeen Standard Bloomberg All Commodity Strategy K-1 Free ETF

Abrdn Bloomberg Industrial Metals Strategy K-1 Free ETF

ProShares Bitcoin Strategy ETF

Fidelity Wise Origin Bitcoin Fund

VanEck Bitcoin Trust

iShares Bitcoin Trust

iShares U.S. Pharmaceuticals ETF

Global X Lithium & Battery Tech ETF

SPDR S&P 500 ETF Trust

SPDR S&P Biotech ETF

Hello! This week's ETF Wrap digs into the slump in ETF flows in April and investor positioning around commodities as inflation worries persist.

Why investor appetite for commodity funds picked up despite ETF flows broadly seeing ‘pretty big drop' in April

Cannabis stocks have gone parabolic. Tilray Brands (TLRY) stock jumped by over 39% on Tuesday while Canopy Growth (CGC) soared by over 78%.

Here's the risk for buying TLRY, CGC, MSOS, and SNDL stocks

WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country.

U.S. poised to ease restrictions on marijuana in historic shift, though it'll remain controlled substance

The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.

US plans to reclassify cannabis as less dangerous drug

The U.S. Drug Enforcement Administration (DEA) is moving marijuana from Schedule I to Schedule III under the Controlled Substances Act, and pending approval from the White House Office of Management and Budget. Rescheduling cannabis would allow U.S. cannabis operators to take federal tax deductions, potentially saving them millions in taxes. Canadian cannabis stocks may not directly benefit from the changes in U.S. regulations and may not be a reliable investment option.

MSOS: Best Play On U.S. Cannabis Regulations

Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug.

Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug

Cannabis stocks were up sharply on Tuesday on a report by the Associated Press that the U.S. Drug Enforcement Administration is poised to propose the lowering of cannabis to a Schedule III controlled substance. For more than 50 years, cannabis has been a Schedule I substance under federal law, in the same bucket as heroin and fentanyl.

Cannabis stocks rally as AP reports imminent rescheduling proposal by DEA

Expectations for a long-delayed measure that would open up the federal banking system to legal-cannabis companies have been dashed this week, an executive at a large dispensary-payments company told MarketWatch.

Cannabis banking measure to be left out of FAA bill, industry exec says

April 20th could be a critical turning point for US-based cannabis stocks as investors await potential regulatory reform. The MSOS ETF offers a highly liquid way to invest in US-based cannabis operators. Rescheduling cannabis to Schedule III and potential adult-use legalization in Florida are significant catalysts for the sector.

MSOS: 4/20 Is Cannabis Day - Significant Implications For Investors

With April 20 approaching (a notable cannabis celebration indeed), thoughts may turn to investing in marijuana stocks. However, beyond the symbolic date, imminent catalysts could drive significant growth in this sector for speculators and those wishing well on the providers of sticky icky turning higher.

High Hopes: Could 4/20 Light Up a Cannabis Stock Rally?

First Trust SkyBridge Crypto Industry and Digital Economy ETF

SPDR Gold Trust

U.S. Global GO GOLD and Precious Metal Miners ETF

Simplify Interest Rate Hedge ETF

FolioBeyond Rising Rates ETF

Sprott Junior Gold Miners ETF

iShares Silver Trust

iShares MSCI Global Silver Miners ETF

Wall Street delivered a decent performance in March. With rates rising to start April, let's look at the key ETF stories of March that may hit headlines in April too.

News for AdvisorShares Pure US Cannabis ETF ETF (MSOS)